| Plasmion–Shimadzu: investment, 202603 acquisition 75% majority by Shimadzu with founders continuing to hold 25% |
2026-03-23 |
| Biocare Medical–Agilent: investment, 200603 acquisitiion $950m in cash by Agilent from investor group led by Excellere Parnters + GHO Capital Partners |
2026-03-09 |
| Univ Kiel–Bruker: CellScape XR platform, 2002602 supply + collab research UKSH Kiel has been early customer |
2026-02-25 |
| Buck Institute–Nautilus Biotechnology: proteomics instrument, 202602 supply existent Buck Institute is early customer for new Voyager Platform |
2026-02-24 |
| Cubase Bio–Almi Invest: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-investor Almi Invest |
2026-02-17 |
| Cubase Bio–EU (govt): grant, 202602c grant €2m from EIC Transition Programme |
2026-02-17 |
| Cubase Bio–Illumina: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-investor Illumina Ventures |
2026-02-17 |
| Cubase Bio–Life Science Invest: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-investor Life Science Invest |
2026-02-17 |
| Cubase Bio–Nordic Science Investments: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-lead investor NSI |
2026-02-17 |
| Cubase Bio–OTHER: investment, 202602 financing totalling €3.9m in private capital + convertibles incl several undisclosed private investors |
2026-02-17 |
| Cubase Bio–SEVERAL: investment, 202602 CubaseBio emerges with €3.9m in financing in private capital + convertibles(!) |
2026-02-17 |
| Cubase Bio–Voima Ventures: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-lead investor Voima Ventures |
2026-02-17 |
| Masimo–Danaher: investment, 202602– acquisition $9.9b in cash net of cash/debt at $180/share SIGNED |
2026-02-17 |
| Agilent–ABB: lab automation technology, 202602 collab existent integration of Agilent instruments into muli-vendor systems of ABB Robotics |
2026-02-04 |
| Agilent–Bico: lab automation technology, 202602 collab existent integration of Agilent instruments into muli-vendor systems of Biosero |
2026-02-04 |
| Agilent–HighRes Biosolutions: lab automation technology, 202602 collab existent integration of Agilent instruments into muli-vendor systems of HRBS |
2026-02-04 |
| Agilent–UniteLabs: lab automation technology, 202602 collab existent integration of Agilent instruments into muli-vendor systems of Unite Labs |
2026-02-04 |
| Agilent–Siemens: laboratory software, 202602– collab expansion to enhance interoperability of OpenLab CDS with Virscidian Analytical Studio s/w |
2026-02-03 |
| Accellix–Mérieux: investment, 202601 acquisition remaining 90% of Accellix by bioMérieux for €35m in cash |
2026-01-22 |
| Nuclera–SEVERAL: investment, 202601 financing round Series C extension $12m bringing total Series C to $87m |
2026-01-13 |
| PathoQuest–Charles River: investment, 202601– acquisition of PathoQuest by Charles River SIGNED |
2026-01-12 |
| TOFwerk–Bruker: investment, 202601 acquisition of remaining 60% ownership stake €na by Bruker |
2026-01-08 |
| Sopat–Endress+Hauser: investment, 202601 acquisition €na of Sopat GmbH + sub Parsum GmbH by Endres+Hauser |
2026-01-01 |
| Tescan–Shimadzu: investment, 202512– acquisition $678m of Tescan a.s. from Carlyle |
2025-12-25 |
| Exact Sciences–Abbott: investment, 202511– acquisition $21b via cash tender offer at $105/share ANNOUNCED |
2025-11-20 |
| Evosep–Nordic Capital: investment, 202511 investment €na making Nordic Capital majority shareholder of Evosep |
2025-11-18 |
| mzio–Bright Giant: mass spectrometry software, 202511 collab product integration of mzmine s/w + SIRIUS s/w |
2025-11-11 |
| ACD/Labs–Revvity: investment, 202511– acquisition of ACD/Labs by Revvity definitive agreement announced |
2025-11-10 |
| Envue Technologies–NanoTemper: investment, 202511 acquisition of Envue by NanoTemper |
2025-11-05 |
| EMC Industrial Group (NZ)–Endress+Hauser: investment, 202511 acquisition of process measurement business of EMC + integration into EH New Zealand |
2025-11-01 |
| Clario–Thermo Fisher: investment, 202510– acquisition $9b in cash plus earnouts and milestones SIGNED |
2025-10-29 |
| Redberry–Lonza: investment, 202510–202601 acquisition of Redberry SAS by Lonza |
2025-10-27 |
| JSR Corp–Merck (DE): investment, 202510–202604 acquisition of JSR Life Sciences chromatography business in Belgium by Merck |
2025-10-15 |
| Labomatic Instruments–Knauer: investment, 202510 acquisition of Labomatic by Knauer |
2025-10-15 |
| BigOmics–SEVERAL: investment, 202510 financing round 1st tranche $1.6m from Diffusion Capital Partners + business angels + TiVentures et al |
2025-10-08 |
| Univ London–Enamine: chemical compound libraries, 202509– supply + collab Enamine to supply fluorinated compounds for FBDD to ICR |
2025-09-23 |
| Aspect Analytics–SEVERAL: investment, 202509 financing round Series A €10m led by PMV + Capricorn Healthtech Fund II |
2025-09-09 |
| Dash Bio–Aligned Fund: investment, 202507 financing round totalling $11m incl lead investor The Aligned Fund |
2025-07-23 |
| Dash Bio–Cybernetix Ventures: investment, 202507 financing round totalling $11m incl co-investor Cybernetix Ventures |
2025-07-23 |
| Dash Bio–Drive Capital: investment, 202507 financing round totalling $11m incl co-investor Drive Capital |
2025-07-23 |
| Dash Bio–Freestyle Capital: investment, 202507 financing round totalling $11m incl co-investor Freestyle Capital |
2025-07-23 |
| Dash Bio–LifeX Ventures: investment, 202507 financing round totalling $11m incl co-investor LifeX Ventures |
2025-07-23 |
| Dash Bio–SEVERAL: investment, 202507 financing round $11m led by The Aligned Fund |
2025-07-23 |
| Dash Bio–Swift Ventures: investment, 202507 financing round totalling $11m incl co-investor Swift Ventures |
2025-07-23 |
| Becton Dickinson–Waters: investment, 202507–202602 merger acquisition of BD Biosciences & Diagnostics by Waters valued at $17.5b with $4b in cash |
2025-07-14 |
| Applied Technical Services–SGS: investment, 202507–202601 acquisition $1.235b cash-/debt-free with <$100m in shares + rest in cash |
2025-07-02 |
| CodeWrights–Endress+Hauser: investment, 202507 acquisition of remaining 33% in joint venture CodeWrights GmbH from Pepperl+Fuchs |
2025-07-01 |
| Standard BioTools–Illumina: investment, 202506– acquisition of SomaLogic by Illumina for $350m cash upfront + $75m milestones |
2025-06-23 |
| Day Zero Diagnostics–Mérieux: investment, 202506 acquisition <$25m of assets of Day Zero Diagnostics by bioMérieux |
2025-06-16 |
| Synexa Life Sciences–Waters: mass spectrometer, 202506 supply + collab as one of first customers for new Xevo TQ Absolute XR mass spectrometer |
2025-06-10 |
| Biocrates–Bruker: investment, 202506 acquisition €na by Bruker Corporation |
2025-06-03 |
| Cytespace Africa Laboratories–MLM Medical Labs: investment, 202506 acquisition of Cytespace by MLM |
2025-06-03 |
| Halo Labs–Waters: investment, 202505 acquisiton of Halo Labs by Waters |
2025-05-21 |
| Bruker–Siscapa: MS-based proteomics, 2020505– collab strategic Biognosys beomces preferred service provider for Siscapa tech to biopharma customers |
2025-05-19 |
| PeptiSystems–Asahi Kasei: peptide synthesis, 202505– collab ww excl integration of Thesys ACS Ergo synthesis column of AKBA into PeptiPro platform |
2025-05-15 |
| Umlaut.bio–Baden-Würrtemberg (govt): investment, <=202505 seed financing round incl investor L-Bank via InnoGrowth BW programme |
2025-05-13 |
| Umlaut.bio–High-Tech Gründerfonds: investment, <=202505 seed financing round incl investor HTGF |
2025-05-13 |
| Umlaut.bio–LBBW: investment, <=202505 seed financing round incl investor LBBW Venture Capital |
2025-05-13 |
| Umlaut.bio–SEVERAL: investment, <=202505 seed financing round €2m with HTGF + LBBW Venture Capital + L-Bank |
2025-05-13 |
| Chayon Laboratories–Nuclera: eProtein Discovery system, 202505– collab distribution by Chayon Laboratories Inc in South Korea |
2025-05-06 |
| Cold Spring Biotech–Nuclera: eProtein Discovery system, 202505– collab distribution by Cold Spring Biotech in Taiwan |
2025-05-06 |
| Kiko Tech–Nuclera: eProtein Discovery system, 202505– collab distribution by Kiko Tech Co Ltd in Japan |
2025-05-06 |
| MineBio Life Sciences–Nuclera: eProtein Discovery system, 202505– collab distribution by MineBio Life Sciences Ltd in China |
2025-05-06 |
| ScienceWerke–Nuclera: eProtein Discovery system, 202505– collab distribution by Sciencewerke Pte Ltd in Singapore |
2025-05-06 |
| Yair Technologies–Nuclera: eProtein Discovery system, 202505– collab distribution by Yair Or Technologies Ltd in Israel |
2025-05-06 |
| Biotage–KKR: investment, 202504– public takeover offer by RWK BidCo AB valuing Biotage at SEK11.6b at SEK1.65/share (KKR already owns 17%) |
2025-04-22 |
| Recipe–Bruker: investment, 202504 majority investment €na by Bruker in Recipe Chemicals + Instruments GmbH |
2025-04-16 |
| Ridom–Bruker: investment, 202504 majority investment €na by Bruker in Ridom GmbH |
2025-04-11 |
| 1st PhileKorea–Sphere Bio: cell analysis technology, 202504– distribution for Sphere Bio in South Korea by 1st PhileKorea |
2025-04-09 |
| As One Corp–Sphere Bio: cell analysis technology, 202504– distribution for Sphere Bio in Japan by 1st PhileKorea |
2025-04-09 |
| Bang Trading–Sphere Bio: cell analysis technology, 202504 distribution existent for Sphere Bio in Thailand by Bang Trading |
2025-04-09 |
| Cold Spring Biotech–Sphere Bio: cell analysis technology, 202504 distribution existent for Sphere Bio in Taiwan by Cold Spring Biotech |
2025-04-09 |
| Decode Science–Sphere Bio: cell analysis technology, 202504– distribution for Sphere Bio in Australia + New Zealand by Decode Science |
2025-04-09 |
| Everlife Research Instruments–Sphere Bio: cell analysis technology, 202504– distribution for Sphere Bio in Singapore by Everlife |
2025-04-09 |
| Gene Company–Sphere Bio: cell analysis technology, 202504 distribution existent for Sphere Bio in China + Hong Kong by Gene Company |
2025-04-09 |
| Premas Life Sciences–Sphere Bio: cell analysis technology, 202504– distribution for Sphere Bio in India + Bangladesh by Premas Life Sciences |
2025-04-09 |
| Bico–Sartorius: investment, 202504–202507 acquisition 100% of MatTek Corp + Visikol Inc on cash/debt-free basis for $80m by Sartorius Lab Holding GmbH |
2025-04-04 |
| UniteLabs–Acurio Ventures: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor Acurio Ventures |
2025-04-03 |
| UniteLabs–Lana Ventures: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor LANA Ventures |
2025-04-03 |
| UniteLabs–NAP: investment, 202504 pre-seed financing round totalling €2.77m incl lead investor NAP |
2025-04-03 |
| UniteLabs–OMA Business Angels: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor OMA Business Angels |
2025-04-03 |
| UniteLabs–Push Ventures: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor PUSH |
2025-04-03 |
| UniteLabs–SEVERAL: investment, 202504 pre-seed financing round €2.77m led by NAP |
2025-04-03 |
| Dotmatics–Siemens: investment, 202502–202507 acquisition $5.1b of Dotmatics from Insight Partners |
2025-04-02 |
| OmicScouts–Momentum Biotechnologies: investment, 202503 acquisition of OmicScouts GmbH by Momentum Biotechnologies |
2025-03-05 |
| Solventum–Thermo Fisher: investment, 202502– acquisition $4.1b in cash of purification + filtration business by Thermo Fisher |
2025-02-25 |
| DeepEn–MBG Thüringen: investment, 202502 seed financing round totalling € 7-digit incl investor MBG Thüringen |
2025-02-17 |
| DeepEn–SEVERAL: investment, 202502 seed financing round € 7-digit from bm|t + MBG Thüringen + Sparkasse-Jena-Holzland |
2025-02-17 |
| DeepEn–Sparkassen (DE): investment, 202502 seed financing round totalling € 7-digit incl investor Sparkasse Jena-Saale-Holzland |
2025-02-17 |
| DeepEn–Thuringia (govt): investment, 202502 seed financing round totalling € 7-digit incl investor bm|t |
2025-02-17 |
| Mobilion–ICR: public relations, 202502 service existent ICR Healthcare is media contact |
2025-02-13 |
| Mobilion–Scott Partnership: public relations, 202505 service existent Scott PR is media contact |
2025-02-13 |
| Stellaromics–Catalyst4: investment, 202502 financing round Series B totalling $80m incl lead investor Catalyst4 |
2025-02-11 |
| Stellaromics–Oak Street Communications: public relations, 202502 service existent Oak Street is media contact for Stellaromics |
2025-02-11 |
| Stellaromics–SEVERAL: investment, 202502 financing round Series B $80m led by Catalyst4 |
2025-02-11 |
| Stellaromics–Stanford Univ: investment, 202502 financing round Series B totalling $80m incl co-investor Stanford University Ventures |
2025-02-11 |
| Akribion–Bruker: investment, 202502 seed financing round totalling €8m incl co-investor Bruker Invest |
2025-02-04 |
| Akribion–High-Tech Gründerfonds: investment, 202502 seed financing round totalling €8m incl co-investor HTGF |
2025-02-04 |
| Akribion–Optimum Strategic Communications: public relations, 202502 service existent by Optimum |
2025-02-04 |
| Akribion–SEVERAL: investment, 202502 seed financing round €8m led by Carma Fund + RV Invest |
2025-02-04 |
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spec-capital-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
